在移植接受者中,塔克罗利斯和沃里科纳之间的相互作用的种群动态分析
Zhi-Hua Sun1,2, Yi-Chang Zhao1,3,4, Jia-Kai Li1,3,4
1International Research Center for Precision Medicine, Transformative Technology and Software Services, Changsha, Hunan, China.
Frontiers in pharmacology
|February 13, 2025
概括
这项研究开发了一种药理动力学模型,用于接受塔克罗利斯和沃里可纳的移植患者. 它发现伏利康纳会影响塔克罗利斯的清除,帮助优化剂量.
科学领域:
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 临床药房 临床药房
背景情况:
- 在脏移植接受者中同时使用塔克罗利斯和沃里康纳可能会产生药物相互作用的风险.
- 这些相互作用可能会导致严重的不良事件,需要谨慎管理.
研究的目的:
- 在接受利康纳的脏移植患者中开发塔克罗利斯的种群药动力学模型.
- 为了更好地理解和量化tacrolimus和voriconazole之间的药物相互作用.
主要方法:
- 从51名脏移植接受者收集塔克罗利斯血液样本和实验室数据.
- 使用Phoenix软件 (8.1版本) 开发一个药理动力学预测模型.
- 通过配套图表,引导分析和视觉预测检查 (VPC) 评估模型性能.
主要成果:
- 在沃里康纳的度和塔克罗利斯清除率之间观察到显著的负相关性.
- 血小板计数与塔克罗利斯清除有显著的正相关性.
- 红细胞计数与塔克罗利斯清除有显著的负相关性.
结论:
- 对于这个患者群体,成功建立了一个强大的群体药理动力学模型.
- 该模型表现出良好的预测性能,提供了有价值的临床见解.
- 这些发现支持优化移植患者与voriconazole同时使用的tacrolimus剂量策略.
相关概念视频
Renal Failure: Dose Adjustments
60
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
60
Analysis of Population Pharmacokinetic Data
218
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
218
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
161
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
161
Drug Concentration Versus Time Correlation
590
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
590
Time Course of Drug Effect
1.9K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
1.9K
Pulmonary Tuberculosis I
220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220


